Key result
Pharmacist-led interventions in urgent care are linked to a ~54 mmHg systolic blood pressure reduction.
Why the study?
Hypertension control remains suboptimal, and while pharmacist-led care shows benefit in primary care, its impact in urgent care settings is not well-studied.
Does pharmacist-led intervention reduce blood pressure in patients with hypertension presenting to urgent care without a primary care provider?
Observational (n=62)
No
Does pharmacist-led intervention reduce blood pressure in patients with hypertension presenting to urgent care without a primary care provider?
Mean Difference: 54.3
Absolute Event Rate: 124.1% vs 178.4%
Pharmacist-led interventions in urgent care for patients without primary care access significantly reduce blood pressure and achieve high rates of guideline-directed control.
May support pharmacist integration into urgent care hypertension management; extends primary care evidence but leaves open need for randomized trials.
Background: Hypertension control remains suboptimal, contributing to preventable cardiovascular disease events, particularly among patients with limited access to primary care. While pharmacist-led care has demonstrated benefit in primary care settings, its impact in urgent care is not well-studied. This study aimed to evaluate patient-centred outcomes of pharmacist-led interventions for hypertension management in urgent care. Methods: A pilot project was designed to integrate a pharmacist into a team-based care model to evaluate and intervene on hypertension and other cardiovascular risk factors among patients presenting to urgent care without a primary care provider and with hypertension (blood pressure ≥140/90 mmHg). The project was performed at the Metrotown Urgent and Primary Care Centre in British Columbia. A retrospective chart review was performed to evaluate the effectiveness of this project. Results: A total of 62 patients were included (mean age 56 years; 56.5% male). Mean (standard deviation [SD]) baseline systolic/diastolic blood pressure was 178.4 (SD 21.7)/101.2 (SD 14.7) mmHg and decreased to 124.1 (SD 12.0)/77.4 (SD 9.9) mmHg following pharmacist-led care, representing a mean reduction (SD) of 54.3 (SD 19.7)/23.8 (SD 15.0) mmHg. Overall, 82% of patients were discharged from the program after achieving Hypertension Canada guideline-recommended blood pressure targets. Conclusion: In an urgent care setting, pharmacist-led interventions achieved substantial reductions in blood pressure and high rates of guideline-recommended control, supporting this model as a strategy to address gaps in hypertension care for patients without primary care access.
No takes yet. Share an insight, caveat, or question.
A 2026 study conducted an observational in Hypertension (n=62). Pharmacist-led hypertension management vs. Baseline was evaluated on Systolic blood pressure (MD 54.3 mmHg). Pharmacist-led interventions in urgent care achieved a mean reduction in systolic/diastolic blood pressure of 54.3/23.8 mmHg, with 82% of patients achieving guideline-recommended targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: